Showing results (101-110 of 629) with videos related to

Sort By:
Pageof 63
Expert Review of Cardiovascular Therapy|February 9, 2010
Mechanism of action and clinical development of ticagrelor, a novel platelet ADP P2Y12 receptor antagonistDavide Capodanno, Kodlipet Dharmashankar, Dominick J Angiolillo
Thrombosis and Haemostasis|June 9, 2017
Antithrombotic therapy for acute coronary syndrome: Past, present and futureDirk Sibbing, Dominick J Angiolillo, Kurt Huber
Giornale Italiano Di Cardiologia (2006)|May 13, 2011
[Antiplatelet and anticoagulant therapy in elderly patients]Davide Capodanno, Dominick J Angiolillo, Corrado Tamburino
European Heart Journal|December 2, 2009
Platelet thrombin receptor antagonism and atherothrombosisDominick J Angiolillo, Davide Capodanno, Shinya Goto
Thrombosis and Haemostasis|July 26, 2013
Impact of aspirin dose on adenosine diphosphate-mediated platelet activities. Results of an in vitro pilot investigationAntonio Tello-Montoliu, Estela Thano, Fabiana Rollini, et al.
Journal of Translational Medicine|April 13, 2018
Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary interventionLarisa H Cavallari, Francesco Franchi, Fabiana Rollini, et al.
Therapeutic Advances in Cardiovascular Disease|December 12, 2019
Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical useDavide Capodanno, Rocco P Milluzzo, Dominick J Angiolillo
Future Cardiology|February 3, 2021
Canakinumab for secondary prevention of coronary artery diseaseLuis Ortega-Paz, Davide Capodanno, Dominick J Angiolillo
Expert Review of Cardiovascular Therapy|July 31, 2010
Update on the clinical development of cangrelorMasafumi Ueno, José Luis Ferreiro, Dominick J Angiolillo
Pageof 63